1.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559
2.
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
by Anderson, Simon G
Heart (British Cardiac Society), 2016-11, Vol.102 (21), p.1750-1756
3.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2
4.
Rapid Blood Pressure Lowering According to Recovery at Different Time Intervals after Acute Intracerebral Hemorrhage: Pooled Analysis of the INTERACT Studies
by Wang, Xia
Cerebrovascular diseases (Basel, Switzerland), 2015-04, Vol.39 (3-4), p.242-248
5.
Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis
by Woodward, T.S
European archives of psychiatry and clinical neuroscience, 2014, Vol.264 (8), p.673-682
6.
A prospective, observational study of Xigris Use in the United States (XEUS)
by Steingrub, Jay S., MD
Journal of critical care, 2010, Vol.25 (4), p.660.e9-660.e16
Filter electronic articles 6 Hits
Remove Filters
- Treatment Outcome
- Humans (6)
- Aged
- Science & Technology (5)
- Life Sciences & Biomedicine (5)
- Female (5)
- Risk Factors (3)
- Mortality (3)
- Young Adult (3)
- Adolescent (3)
- Clinical Medicine (3)
- Blood Pressure (3)
- Cardiovascular System & Card... (3)
- Anticholesteremic Agents - Admin... (2)
- Analysis (2)
- Aged, 80 And Over (2)
- Amides (2)
- less ...